Premium
MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis
Author(s) -
Pourhanifeh Mohammad H.,
MahjoubinTehran Maryam,
Shafiee Alimohammad,
Hajighadimi Sarah,
Moradizarmehri Sanaz,
Mirzaei Hamed,
Asemi Zatollah
Publication year - 2020
Publication title -
iubmb life
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.132
H-Index - 113
eISSN - 1521-6551
pISSN - 1521-6543
DOI - 10.1002/iub.2211
Subject(s) - microvesicles , microrna , stromal cell , multiple myeloma , tumor microenvironment , biology , cancer research , pathogenesis , gene silencing , cancer cell , bone marrow , microbiology and biotechnology , cancer , function (biology) , gene , immunology , tumor cells , genetics
Multiple myeloma (MM), an incurable hematologic malignancy of plasma cells increasing in the bone marrow (BM), has a complex microenvironment made to support proliferation, survival, and drug resistance of tumor cells. MicroRNAs (miRNAs), short non‐coding RNAs regulating genes expression at posttranscriptional level, have been indicated to be functionally deregulated or abnormally expressed in MM cells. Moreover, by means of miRNAs, tumor microenvironment also modulates the function of MM cells. Consistently, it has been demonstrated that miRNA levels regulation impairs their interaction with the microenvironment of BM as well as create considerable antitumor feature even capable of overcoming the protective BM milieu. Communication between cancer stromal cells and cancer cells is a key factor in tumor progression. Finding out this interaction is important to develop effective approaches that reverse bone diseases. Exosomes, nano‐vehicles having crucial roles in cell‐to‐cell communication, through targeting their cargos (i.e., miRNAs, mRNAs, DNAs, and proteins), are implicated in MM pathogenesis.